News

GLMD

Galmed Pharmaceuticals Announces FDA Clearance of IND of Aramachol™ for the Treatment of Patients with HIV-Associated Lipodystrophy and Nonalcoholic Fatty Liver Disease

Press Releases | Equities.com |

TEL AVIV, Israel, Dec. 1, 2015 -- Galmed Pharmaceuticals Ltd. ($GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of


Galmed Pharmaceuticals Announces Commencement of Patient Screening for the ARREST Study in Europe, and Reports Third Quarter 2015 Financial Results

Press Releases | Equities.com |

- Conference Call and Webcast Today at 8:30 a.m. EST / 5:30 a.m. PST - TEL AVIV, Israel, Nov. 9, 2015 -- Galmed Pharmaceuticals Ltd. ($GLMD) ("Galmed" or the "Company"), a


Galmed Pharmaceuticals Third Quarter 2015 Conference Call and Webcast Scheduled for November 9, 2015

Press Releases | Equities.com |

TEL AVIV, Israel, Nov. 2, 2015 -- Galmed Pharmaceuticals Ltd. (GLMD) ("Galmed"), a clinical-stage biopharmaceutical company focused on the development and commercialization of a


Galmed Pharmaceuticals Announces the Commencement of Patient Screening in the ARREST Study in the United States and Latin America, and Reports Second Quarter 2015 Financial Results

Press Releases | Equities.com |

-- Conference Call and Webcast Today at 8:30 a.m. EDT / 5:30 a.m. PDT -- TEL AVIV, Israel, Aug. 13, 2015 -- Galmed Pharmaceuticals Ltd. (GLMD) ("Galmed"), a clinical-stage


Galmed Pharmaceuticals Second Quarter 2015 Conference Call and Webcast Scheduled for August 13, 2015

Galmed Pharmaceuticals Ltd. - $GLMD | Equities.com |

TEL AVIV, Israel, Aug. 6, 2015 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. ($GLMD) ("Galmed"), a clinical-stage biopharmaceutical company focused on the development and


Galmed Pharmaceuticals Unfolds the Development of Aramchol™ Non-Invasive Companion Diagnostic Program

Press Releases | Equities.com |

TEL AVIV, Israel, July 8, 2015  -- Galmed Pharmaceuticals Ltd. (GLMD) ("Galmed"), a clinical-stage biopharmaceutical company focused on the development and commercialization


7 Micro-Cap Biotech Stocks with Massive Potential

The Life Sciences Report | Equities.com |

Biotechnology can be daunting to comprehend, but understanding is critical to successful investment. BioWatch News Founder Alan Leong has a nose for growth names, and his goal is to make their


Biotech Stocks With Considerable Upside Potential

The Life Sciences Report | Equities.com |

Everybody knows that biotech ideas can become huge gainers for investors, but understanding the technology platforms, the unmet needs and the valuations can be daunting, especially in spaces where


IPO Report: Galmed Pharmaceuticals (GLMD)

Francis Gaskins | Equities.com |

Galmed Pharmaceuticals (GLMD) is a clinical-stage biopharmaceutical company headquartered in Tel Aviv, Israel,. Four other companies are scheduled for the week of March 10, 2014.  The full


5 IPOs Scheduled for the Week of March 10

Francis Gaskins | Equities.com |

The full IPO calendar is available at IPOpremium.  Scheduled IPOs are ranked by IPO size. (1) Based in Greenwich, CT, Diamond S Shipping Group (DSG) scheduled a $210 million IPO on the NYSE



Discover: Trending Events

United Nations
Blockchain for Europe
Humanity 2.0
World Economic Forum